Cargando…

Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

BACKGROUND: Our aim was to determinate bone mineral density (BMD), levels of biochemical markers and cytokines in children with chronic hepatitis B treated with interferon (IFN)-alpha and to investigate effect of IFN-alpha therapy on these variables. To the best of our knowledge, this is first study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gur, Ali, Dikici, Bünyamin, Nas, Kemal, Bosnak, Mehmet, Haspolat, Kenan, Sarac, Aysegul Jale
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1242225/ https://www.ncbi.nlm.nih.gov/pubmed/16171525 http://dx.doi.org/10.1186/1471-230X-5-30

Ejemplares similares

The relationship between educational level and bone mineral density in postmenopausal women
por: Gur, Ali, et al.
Publicado: (2004)

Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones
por: Cevik, Remzi, et al.
Publicado: (2004)

Cortisol and hypothalamic–pituitary–gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones
por: Gur, Ali, et al.
Publicado: (2004)

Interferon Status in Children during Acute Respiratory Infections. Therapy with Interferon
por: Obraztsova, E. V., et al.
Publicado: (2009)

Interferon lambdas: the next cytokine storm
por: Kelly, Christabel, et al.
Publicado: (2011)

Interferon-λ in HCV Infection and Therapy
por: Pagliaccetti, Nicole E., et al.
Publicado: (2010)

The Role of Interferon in Hepatitis B Therapy
por: Rijckborst, Vincent, et al.
Publicado: (2010)

Lichen striatus after interferon therapy
por: Mask-Bull, Lisa, et al.
Publicado: (2015)

Psychiatric Adverse Effects Of Interferon Therapy
por: COMAN, HORIA GEORGE, et al.
Publicado: (2013)

Interferon therapy for preventing COPD exacerbations
por: Mehta, Meenu, et al.
Publicado: (2020)

Interferon-based therapies in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
por: Ozkan, Tanju Basarir, et al.
Publicado: (2007)

Lambda Interferons: New Cytokines with Old Functions
por: Hamming, Ole J., et al.
Publicado: (2010)

Tumor necrosis factor and interferon: cytokines in harmony
por: Bartee, Eric, et al.
Publicado: (2008)

Interferon and cytokine responses to SARS-coronavirus infection
por: Thiel, Volker, et al.
Publicado: (2008)

Interferons as cytokines regulating leukocyte functions in vivo
por: Virelizier, J.-L.
Publicado: (1985)

Interferon Family Cytokines in Obesity and Insulin Sensitivity
por: Huang, Ling-Yu, et al.
Publicado: (2022)

Selective Hyper-responsiveness of the Interferon System in Major Depressive Disorders and Depression Induced by Interferon Therapy
por: Schlaak, Joerg F., et al.
Publicado: (2012)

Delicate Situation of Bipolar Disorder and Interferon Therapy
por: Aarab, Chadya, et al.
Publicado: (2018)

Interferon targeted therapies in systemic lupus erythematosus
por: Misra, Durga Prasanna, et al.
Publicado: (2017)

Recent Progress in Interferon Therapy for Myeloid Malignancies
por: Healy, Fiona M., et al.
Publicado: (2021)

Topical interferon therapy in uveitic macular edema
por: Kawali, Ankush, et al.
Publicado: (2022)

The effect of interferon in the therapy of severe coronavirus infection
por: Shajari, Rasoul, et al.
Publicado: (2023)

Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health Study
por: Apalset, E M, et al.
Publicado: (2014)

Cell-based interferon gene therapy using proliferation-controllable, interferon-releasing mesenchymal stem cells
por: Tsujimura, Mari, et al.
Publicado: (2019)

Interferon-γ and voriconazole combined therapy for refractory meningeal coccidioidomycosis in a patient with interferon-γ deficiency
por: De la Hoz, Alejandro, et al.
Publicado: (2020)

Influence of Vitamin K on Bone Mineral Density and Osteoporosis
por: Elshaikh, Abeer O, et al.
Publicado: (2020)

Evolution of Interferons and Interferon Receptors
por: Secombes, Chris J., et al.
Publicado: (2017)

Bone mineral density response prediction following osteoporosis treatment using machine learning to aid personalized therapy
por: Tanphiriyakun, Thiraphat, et al.
Publicado: (2021)

Adjuvant therapy of melanoma with interferon: lessons of the past decade
por: Ascierto, Paolo A, et al.
Publicado: (2008)

Evolution of Interferon-Based Therapy for Chronic Hepatitis C
por: Chen, Chun-Hao, et al.
Publicado: (2010)

Hyercalcemia induced by interferon therapy in chronic hepatitis C
por: Albaker, Waleed I.
Publicado: (2012)

Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis
por: Chin, Kai Ling, et al.
Publicado: (2017)

Identifying responders and nonresponders to interferon therapy in multiple sclerosis
por: Prosperini, Luca, et al.
Publicado: (2014)

The interferon system as a basis for antiviral therapy or prophylaxis
por: Billiau, A.
Publicado: (1985)

Considering Personalized Interferon Beta Therapy for COVID-19
por: Dorgham, Karim, et al.
Publicado: (2021)

Intensive topical interferon therapy in uveitic macular edema
por: Kawali, Ankush, et al.
Publicado: (2022)

Pegylated Interferon α Therapy in Chronic Delta Hepatitis: A One-Center Experience
por: Bahcecioglu, Ibrahim Halil, et al.
Publicado: (2015)

Interferon and Interferon Inducers in the Treatment of Malignancies
por: Levy, Hilton B., et al.
Publicado: (1970)

Interferon and Interferon Inducers in Protozoal Infections
por: Jahiel, Rene I.
Publicado: (1970)

Cannot write session to /tmp/vufind_sessions/sess_fg0a7s30kbm5cj3q90100bh8cq